RELEUKO
NDC 70121-1570, Filgrastim, injection, solution, from Amneal Pharmaceuticals LLC.
- Product NDC
- 70121-1570
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761082
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1570 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FILGRASTIM480 ug/.8mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70121-1570-1 | 70121157001 | 1 SYRINGE in 1 BOX (70121-1570-1) / .8 mL in 1 SYRINGE |
| 70121-1570-7 | 70121157007 | 10 SYRINGE in 1 BOX (70121-1570-7) / .8 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/74e1ec6e-1630-4654-895c-2bd355f939e7Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70121-1570
Use it
Look up 70121-1570 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1570 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70121-1570. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.